Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101014912> ?p ?o ?g. }
- W2101014912 abstract "The malaria situation has been worsening in Angola, partly due to armed conflict until the recent past and drug-resistant Plasmodium falciparum. Malaria transmission is heterogeneous within the country, and data on drug-resistant malaria in different parts of the country are incomplete. The aim of the present study was to evaluate resistance to 4-aminoquinolines and antifolate drugs in P. falciparum isolates collected in Benguela province, central Angola, using molecular markers. Fingerprick capillary blood was collected from asymptomatic children aged less than 15 years old during a household survey in and around Balombo town in 2010–2011. Samples were screened for P. falciparum by nested PCR. Molecular markers (P. falciparum dihydrofolate reductase [pfdhfr], P. falciparum dihydropteroate synthase [pfdhps], P. falciparum chloroquine resistance transporter [pfcrt], and P. falciparum multidrug-resistance gene 1 [pfmdr1]) were sequenced to determine the key codons associated with drug resistance. A total of 60 blood samples were positive for P. falciparum. Most isolates with successful PCR amplification had mutant pfdhfr alleles, with either double mutant AICNI (69%) or triple mutant AIRNI (21%) haplotypes. A16V, S108T, and I164L substitutions were not found. Many of the isolates were carriers of either SGKAA (60%) or AGKAA (27%) pfdhps haplotype. K540E substitution was absent. There were only two pfcrt haplotypes: wild-type CVMNK (11%) and mutant CVIET (89%). Wild-type pfmdr1 NYSND haplotype was found in 19% of the isolates, whereas single mutant pfmdr1 YYSND and NFSND haplotypes occurred in 48% and 11%, respectively. Double mutant pfmdr1 haplotypes (YFSND and YYSNY) occurred rarely. The results suggest that the high prevalence of mutant pfcrt CVIET haplotype is in agreement with low clinical efficacy of chloroquine observed in earlier studies and that the double pfdhfr mutant AICNI and single pfdhps mutant SGKAA are currently the predominant haplotypes associated with antifolate resistance in Benguela province. The hallmark of clinical resistance observed in East Africa, i.e. triple pfdhfr mutant haplotype (AIRNI) and double pfdhps mutant haplotype (SGEAA), was absent. These molecular findings need to be further evaluated in parallel with clinical studies, in particular with the efficacy of intermittent preventive treatment using sulphadoxine-pyrimethamine in pregnant women and artesunate-amodiaquine for uncomplicated malaria." @default.
- W2101014912 created "2016-06-24" @default.
- W2101014912 creator A5002399237 @default.
- W2101014912 creator A5009660355 @default.
- W2101014912 creator A5017922234 @default.
- W2101014912 creator A5018392105 @default.
- W2101014912 creator A5018892733 @default.
- W2101014912 creator A5035566063 @default.
- W2101014912 creator A5038689037 @default.
- W2101014912 creator A5062237693 @default.
- W2101014912 creator A5066533363 @default.
- W2101014912 date "2015-03-14" @default.
- W2101014912 modified "2023-10-16" @default.
- W2101014912 title "Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola" @default.
- W2101014912 cites W139561384 @default.
- W2101014912 cites W1536971852 @default.
- W2101014912 cites W1543099101 @default.
- W2101014912 cites W1612654345 @default.
- W2101014912 cites W1912462119 @default.
- W2101014912 cites W1976402561 @default.
- W2101014912 cites W1977784023 @default.
- W2101014912 cites W1982497887 @default.
- W2101014912 cites W2000660372 @default.
- W2101014912 cites W2013512668 @default.
- W2101014912 cites W2026507689 @default.
- W2101014912 cites W2032387134 @default.
- W2101014912 cites W2034767282 @default.
- W2101014912 cites W2037119512 @default.
- W2101014912 cites W2042337608 @default.
- W2101014912 cites W2045760978 @default.
- W2101014912 cites W2100077167 @default.
- W2101014912 cites W2104536143 @default.
- W2101014912 cites W2106374162 @default.
- W2101014912 cites W2119412476 @default.
- W2101014912 cites W2120930240 @default.
- W2101014912 cites W2126744330 @default.
- W2101014912 cites W2133889563 @default.
- W2101014912 cites W2136100868 @default.
- W2101014912 cites W2141580274 @default.
- W2101014912 cites W2144382724 @default.
- W2101014912 cites W2152626065 @default.
- W2101014912 cites W2167153421 @default.
- W2101014912 cites W2169362895 @default.
- W2101014912 cites W2171426733 @default.
- W2101014912 cites W2232884085 @default.
- W2101014912 cites W2333050857 @default.
- W2101014912 doi "https://doi.org/10.1186/s12936-015-0634-2" @default.
- W2101014912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4374507" @default.
- W2101014912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25889865" @default.
- W2101014912 hasPublicationYear "2015" @default.
- W2101014912 type Work @default.
- W2101014912 sameAs 2101014912 @default.
- W2101014912 citedByCount "10" @default.
- W2101014912 countsByYear W21010149122016 @default.
- W2101014912 countsByYear W21010149122017 @default.
- W2101014912 countsByYear W21010149122018 @default.
- W2101014912 countsByYear W21010149122019 @default.
- W2101014912 countsByYear W21010149122020 @default.
- W2101014912 countsByYear W21010149122021 @default.
- W2101014912 countsByYear W21010149122023 @default.
- W2101014912 crossrefType "journal-article" @default.
- W2101014912 hasAuthorship W2101014912A5002399237 @default.
- W2101014912 hasAuthorship W2101014912A5009660355 @default.
- W2101014912 hasAuthorship W2101014912A5017922234 @default.
- W2101014912 hasAuthorship W2101014912A5018392105 @default.
- W2101014912 hasAuthorship W2101014912A5018892733 @default.
- W2101014912 hasAuthorship W2101014912A5035566063 @default.
- W2101014912 hasAuthorship W2101014912A5038689037 @default.
- W2101014912 hasAuthorship W2101014912A5062237693 @default.
- W2101014912 hasAuthorship W2101014912A5066533363 @default.
- W2101014912 hasBestOaLocation W21010149121 @default.
- W2101014912 hasConcept C104317684 @default.
- W2101014912 hasConcept C114851261 @default.
- W2101014912 hasConcept C135763542 @default.
- W2101014912 hasConcept C159047783 @default.
- W2101014912 hasConcept C197754878 @default.
- W2101014912 hasConcept C203014093 @default.
- W2101014912 hasConcept C2776992834 @default.
- W2101014912 hasConcept C2777035104 @default.
- W2101014912 hasConcept C2777234095 @default.
- W2101014912 hasConcept C2778048844 @default.
- W2101014912 hasConcept C2778371730 @default.
- W2101014912 hasConcept C54355233 @default.
- W2101014912 hasConcept C86803240 @default.
- W2101014912 hasConcept C97669555 @default.
- W2101014912 hasConceptScore W2101014912C104317684 @default.
- W2101014912 hasConceptScore W2101014912C114851261 @default.
- W2101014912 hasConceptScore W2101014912C135763542 @default.
- W2101014912 hasConceptScore W2101014912C159047783 @default.
- W2101014912 hasConceptScore W2101014912C197754878 @default.
- W2101014912 hasConceptScore W2101014912C203014093 @default.
- W2101014912 hasConceptScore W2101014912C2776992834 @default.
- W2101014912 hasConceptScore W2101014912C2777035104 @default.
- W2101014912 hasConceptScore W2101014912C2777234095 @default.
- W2101014912 hasConceptScore W2101014912C2778048844 @default.
- W2101014912 hasConceptScore W2101014912C2778371730 @default.
- W2101014912 hasConceptScore W2101014912C54355233 @default.
- W2101014912 hasConceptScore W2101014912C86803240 @default.
- W2101014912 hasConceptScore W2101014912C97669555 @default.
- W2101014912 hasIssue "1" @default.